Articles published by Bristol Myers Squibb
![](https://mms.businesswire.com/media/20220407006046/en/785876/5/BMS_LOGO.jpg)
![](https://mms.businesswire.com/media/20220411005025/en/1413609/5/BMSF_Logo.jpg)
![](https://mms.businesswire.com/media/20220323005847/en/785876/5/BMS_LOGO.jpg)
![](https://mms.businesswire.com/media/20220404005930/en/785876/5/BMS_LOGO.jpg)
![](https://mms.businesswire.com/media/20220404005926/en/785876/5/BMS_LOGO.jpg)
![](https://mms.businesswire.com/media/20220404005907/en/785876/5/BMS_LOGO.jpg)
![](https://mms.businesswire.com/media/20220402005036/en/785876/5/BMS_LOGO.jpg)
![](https://mms.businesswire.com/media/20220401005495/en/785876/5/BMS_LOGO.jpg)
![](https://mms.businesswire.com/media/20220325005275/en/785876/5/BMS_LOGO.jpg)
![](https://mms.businesswire.com/media/20220324006050/en/785876/5/BMS_LOGO.jpg)
![](https://mms.businesswire.com/media/20220317005968/en/785876/5/BMS_LOGO.jpg)
![](https://mms.businesswire.com/media/20220304005561/en/1380391/4/Opdualag_Product_Shot.jpg)
![](https://mms.businesswire.com/media/20220313005021/en/1388208/4/BMS_NEKTAR.jpg)
![](https://mms.businesswire.com/media/20220225005538/en/785876/5/BMS_LOGO.jpg)
![](https://mms.businesswire.com/media/20220224006066/en/785876/5/BMS_LOGO.jpg)
![](https://mms.businesswire.com/media/20220224006058/en/785876/5/BMS_LOGO.jpg)
![](https://mms.businesswire.com/media/20220223006231/en/785876/5/BMS_LOGO.jpg)
![](https://mms.businesswire.com/media/20220215005932/en/785876/5/BMS_LOGO.jpg)
![](https://mms.businesswire.com/media/20220215006166/en/785876/5/BMS_LOGO.jpg)
![](https://mms.businesswire.com/media/20220215005925/en/1360778/5/bms_logo_rgb_pos_300-%28002%29.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Bristol Myers Squibb Prices $6 Billion of Senior Unsecured Notes
February 15, 2022
From Bristol Myers Squibb
Via Business Wire
Tickers
BMY
![](https://mms.businesswire.com/media/20220215005760/en/1360107/5/BMS_LOGO.jpg)
Bristol Myers Squibb Announces Tender Offers for an Aggregate Purchase Price of Up to $4.0 Billion
February 15, 2022
From Bristol Myers Squibb
Via Business Wire
Tickers
BMY
![](https://mms.businesswire.com/media/20220214005475/en/785869/5/BMS_Exelixis.jpg)
![](https://mms.businesswire.com/media/20220209005341/en/785876/5/BMS_LOGO.jpg)
Bristol Myers Squibb Enters Into $5 Billion Aggregate Accelerated Share Repurchase Agreements
February 09, 2022
From Bristol Myers Squibb
Via Business Wire
Tickers
BMY
![](https://mms.businesswire.com/media/20220208005429/en/1352077/4/Health_Equity_Infographic_Grantee_list_pg_2.jpg)
![](https://mms.businesswire.com/media/20220204005037/en/785876/5/BMS_LOGO.jpg)
ADDING and REPLACING Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2021
February 04, 2022
From Bristol Myers Squibb
Via Business Wire
Tickers
BMY
![](https://mms.businesswire.com/media/20220204005037/en/785876/5/BMS_LOGO.jpg)
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2021
February 04, 2022
From Bristol Myers Squibb
Via Business Wire
Tickers
BMY
![](https://mms.businesswire.com/media/20220113005630/en/785876/5/BMS_LOGO.jpg)
![](https://mms.businesswire.com/media/20220110005266/en/1322562/4/Century_Logo.jpg)
![](https://mms.businesswire.com/media/20220110005213/en/785876/5/BMS_LOGO.jpg)
Bristol Myers Squibb to Highlight Long-Term Growth Strategy at J.P. Morgan’s 40th Annual Healthcare Conference
January 10, 2022
From Bristol Myers Squibb
Via Business Wire
Tickers
BMY
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.